BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32900569)

  • 1. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.
    Wang L; Du X; Dong JZ; Liu WN; Zhou YC; Li SN; Guo XY; Jiang CX; Yu RH; Sang CH; Tang RB; Long DY; Liu N; Bai R; Macle L; Ma CS
    Clin Res Cardiol; 2019 Dec; 108(12):1371-1380. PubMed ID: 30953181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Meeder J; Kurpesa M; Baluta MM; Proietti M; Tavazzi L; Maggioni AP; Lip GYH;
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):566-572. PubMed ID: 29345382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
    Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-specific association between body mass index and all-cause mortality in patients with atrial fibrillation.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Clin Cardiol; 2020 Jul; 43(7):706-714. PubMed ID: 32352584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China.
    Deng F; Zhang Y; Zhao Q; Deng Y; Gao S; Zhang L; Dong M; Yuan Z; Lei X;
    BMC Cardiovasc Disord; 2020 Jun; 20(1):270. PubMed ID: 32503432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prognosis of atrial fibrillation in diabetic patients: an EORP-AF General Pilot Registry report.
    Fumagalli S; Said SA; Laroche C; Gabbai D; Boni S; Marchionni N; Boriani G; Maggioni AP; Musialik-Lydka A; Sokal A; Petersen J; Crijns HJGM; Lip GYH;
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):172-179. PubMed ID: 29309557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry.
    García-Fernández A; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Ruiz Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Otero D; Anguita M; Lip GYH; Marín F;
    Ann Med; 2020 Sep; 52(6):300-309. PubMed ID: 32500748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients.
    Tian L; Yang YM; Zhu J; Zhang H; Shao XH
    J Diabetes Complications; 2022 Sep; 36(9):108265. PubMed ID: 35914400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: A report from the China atrial fibrillation registry study.
    Jiang C; Lan DH; Du X; Geng YP; Chang SS; Zheng D; Chen JB; Yu RH; Sang CH; Long DY; Tang RB; Zhou YC; Min Y; Lu Y; Dong JZ; Lip GYH; Ma CS
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2759-2766. PubMed ID: 31599040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.
    Murakawa Y; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Minematsu K; Miyamoto S; Hayashi Y; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
    Heart Vessels; 2020 Aug; 35(8):1125-1134. PubMed ID: 32253531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year all-cause mortality risk among atrial fibrillation patients in Middle East with and without diabetes: The Gulf SAFE registry.
    Domek M; Li YG; Gumprecht J; Asaad N; Rashed W; Alsheikh-Ali A; Nabrdalik K; Gumprecht J; Zubaid M; Lip GYH
    Int J Cardiol; 2020 Mar; 302():47-52. PubMed ID: 31948674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B; Yu LT; Gao X; Wang M
    Clin Res Cardiol; 2014 Jul; 103(7):533-42. PubMed ID: 24535378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High variability in bodyweight is associated with an increased risk of atrial fibrillation in patients with type 2 diabetes mellitus: a nationwide cohort study.
    Lee HJ; Choi EK; Han KD; Kim DH; Lee E; Lee SR; Oh S; Lip GYH
    Cardiovasc Diabetol; 2020 Jun; 19(1):78. PubMed ID: 32534567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry.
    Domek M; Gumprecht J; Li YG; Proietti M; Rashed W; Al Qudaimi A; Gumprecht J; Zubaid M; Lip GYH
    Eur J Clin Invest; 2021 Mar; 51(3):e13385. PubMed ID: 32810282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Age on the Association Between Body Mass Index and All-Cause Mortality in Patients with Atrial Fibrillation.
    Wu S; Yang YM; Zhu J; Wan HB; Wang J; Zhang H; Shao XH
    J Nutr Health Aging; 2017; 21(10):1125-1132. PubMed ID: 29188871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and impact of diabetes mellitus on outcomes in patients with nonvalvular atrial fibrillation.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    Yonsei Med J; 2015 Jan; 56(1):62-71. PubMed ID: 25510748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.